A liquid biopsy company using orphan non-coding RNA biomarkers and AI to detect and characterize cancer from a routine blood draw.
Exai Bio / UCSF / Arc Institute / University of California, Davis
Released March 26, 2025
Cell-free RNA language model for liquid biopsy, fusing RNA sequence embeddings with cfRNA abundance across 306 billion pretraining tokens.